32 Flashcards

GI and Surgery

1
Q

Epidemiology UC

A
  • Incidence: 21 per 100,000
  • Prevalence: 240 per 100,000
  • Occurs more in Caucasians and Ashkenazic Jews
  • F:M ratio 1:1
  • Peak incidence in 15-25 and 55-65 years
  • Can present in very young children or elderly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

S+S of UC

A
Relapsing and remitting in nature
Diarrhoea
PR bleeding
Frequency of stools, associated with urgency
Fatigue and malaise
Fever
Mucus discharge

Tachycardia
Fever
Abdominal tenderness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Disease features of UC

A

Only affects the colon, always affects the rectum.

Inflammation limited to the mucosa.

Mucosal atrophy, walls appear thin.

Ulcers are superficial with a broad base.

Malignant potential.

Negatives:
No skin lesions.
No mural thickening, no strictures, no fistulas.
No malabsorption .
No recurrence post-op.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathophysiology of UC

A

Defects in host interaction with intestinal bacteria.
Intestinal epithelial dysfunction.
Inappropriate mucosal immune responses.

TH17 and TH2 are increasingly active.

Defects in epithelial tight junctions increased passage of bacteria to cause a reaction.
Increased cytokine activity.

No specific gene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Investigations for UC

A

FBC - anaemia or thrombocytosis.

LFTs - raised ALP, hypoalbuminaemia, hypokalaemia, hypomagnesaemia.

Raised ESR and CRP.

Test iron, B12, folate.

Foetal calprotectin, usually used for monitoring.
Stool samples for infection,

ANCA positive

Colonoscopy/sigmoidoscopy + biopsy - abnormal erythematous mucosa with ulceration - biopsy for confirmation

Abdominal X-ray to check for perforation.
Double contrast barium enema - lead piping

Foetal calprotectin, usually used for monitoring

Can use CT enterography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Measuring severity of UC

A

Using Truelove and Witt’s severity index

MILD - diarrhoea <4 times /day, no anaemia, no fever, no tachycardia, no weight loss.

MODERATE - diarrhoea 4/5 times per day, Small amount of blood in stool, no fever, no tachycardia, raised CRP (mild).

SEVERE - diarrhoea 6+ times a day, blood in stool, fever, tachycardia, anaemia, raised CRP.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Extracolonic manifestations of UC

A
Uveitis
Pleuritis
Erythema nodosum
Ankylosing spondylitis
Pyoderma gangrenosum

Primary sclerosing cholangitis
MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Management of UC - inducing remission

A
  1. Amniosalicylates - mesalazine
  2. Corticosteroids - oral prednisolone
  3. Immunomodulators - azathioprine, methotrexate, ciclosporin
  4. Mabs - Infliximab in severe cases
  5. Surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Complications of UC

A
  • Haemorrhage
  • Toxic megacolon
  • Colorectal carcinoma
  • Fatty liver
  • Primary sclerosing cholangitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Epidemiology of Crohn’s

A
  • Genetic link - NOD2
  • Smoking is a big risk factor
  • Most common in ileocaecal region
  • Incidence: 4 per 100,000
  • Prevalence: 150 per 100,000
  • Caucasians and Ashkenazic Jews
  • F:M ratio 1.5:1
  • Peak incidence in 15-25 and 50-80 years
  • More common in smokers
  • Can occur in children (usually with FHx)”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Symptoms of Crohn’s

A
Diarrhoea
PR bleeding
Abdominal pain
Weight loss
Fatigue
Mouth ulcers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Features of Crohn’s

A

Any part of GI tract.

Transmural, can form strictures.

Skip lesions.

Oedema and loss of mucosal texture.

Triggered by emotional stresses or smoking.

Cobblestone appearance.

Ulcers deep and knife like.

Fistulas common.

Fat/vitamin malabsorption.

Malignant potential if in colon.

Recurrence post-op is common.

40% ileocecal, 30% small intestine, 25% colon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pathophysiology of Crohn’s

A

Defects in host interaction with intestinal bacteria
Intestinal epithelial dysfunction
Inappropriate mucosal immune responses

TH17 and TH2 are increasingly active

Defects in epithelial tight junctions increased passage of bacteria to cause a reaction
Increased cytokine activity

NOD 2 gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Investigations in Crohn’s

A

FBC - anaemia
Raised CRP
Nutrient deficiency, B12, folate
LFTs hypoalbuminaemia

Stool culture for C.diff
ASCA (not ANCA as in UC)

Endoscopy - ileocolonoscopy + biopsies, occasionally OGD

Abdominal X-ray for perforation

Small bowel follow through - cobblestone appearance

Can have CT enterography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Management of Crohn’s - inducing remission

A
  1. Steroid - prednisolone
  2. Aminosallicylate - mesalazine
  3. Azathioprine / mercaptopurine
  4. Methotrexate
  5. Infiximab or adalimumab

Surgery is last line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Management of Crohn’s - maintenance

A

Azathioprine or mercaptopurine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Extraintestinal features of Crohn’s

A
Uveitis
Migrating polyarthritis
Ankylosing spondylitis
Clubbing
Pyoderma gangrenosum (greater incidence than in UC)
Erythema nodosum
Aphthous ulcers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Classification of Crohn’s disease

A

Crohn’s disease activity index:
<150 remission, 150-300 active, 300+ severe.
Depends on number of stools, pain, well being, extra intestinal manifestations, pyrexia, etc.

Harvey Bradshaw Index
<4 = remission, 5-8 moderate, 8+ severe
19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Complications of Crohn’s

A
  • Malabsorption (short loop/bowel syndrome due to repeated resection)
  • Stricturing
  • Anal lesions (60%): fissures, fistula
  • Perforation
  • Cholelithiasis
  • Fatty liver
  • Increased risk of malignancy of SI but less frequent than ulcerative colitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Causes of upper GI bleeding

A

Gastritis - dyspepsia

Oesophagitis - dyspepsia , worse on lying

Gastric/duodenal ulcer - nausea, vomiting, weight loss, dyspepsia

Oesophageal/gastric varices - Hx of liver disease, alcohol excess

Cancer - malaise, weight loss, vomiting, early satiety

Mallory-Weiss tear = young, history of vomiting, small amounts

Gastric/duodenal erosions = NSAID or alcohol history, epigastric pain

Drugs = aspirin, NSAIDs, steroidsm thrombolytics, anticoagulants

Rare = bleeding disorders, aorto-enteric fistula, Meckel’s diverticulum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Symptoms and signs of upper GI bleeding

A

Fresh haematemesis or coffee grounds
Melaena
Medication and alcohol history

Tachycardic and hypotensive
Cap refill may be reduced
Postural BP drop
Anaemia - pallor

Stigmata of liver disease - hepatic flap, caput medusa, ascites, hepatomegaly, spider naevi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Investigations for GI bleeding

A

FBC - haemoglobin and MCV (if low MCV, may be chronic).
U+E - raised urea to creatinine ratio.
LFTs - clotting and signs of chronic liver disease.

Upper GI endoscopy - NBM for 4 hours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Classification of GI bleeds

A

Rockall risk scoring:
- relies on BP, HR, endoscopy
Low risk - 0-1, moderate 2-3, severe 4+

Blatchford score:
No endoscopy required
Predicts who needs intervention - 6+ needs intervention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Management of upper GI bleed

A

Non-variceal:

  • Resuscitate
  • Endoscopy within 4/24 hours, urgent/non-urgent, no routine PPI pre-endoscopy

Variceal:

  • Resuscitate
  • Terlipressin
  • Variceal band, ligation/adrenaline injections/ TIPS/ glue
  • Balloon tamponade (Sengstaken-Blakemore tube)
  • Antibiotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Side effects of blood transfusions

A

Hypothermia as products stored at fridge temperature.

Hypocalcaemia - blood contains citrate which chelates calcium.

Hyperkalaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Causes of lower GI bleeding visible

A
Haemorrhoids
Fissures
Carcinoma
Polyps
Proctitis
Diverticular disease
IBD
Angiodysplasia
Infection - E.coli, shigella, salmonella, campylobacter
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Investigations for lower GI bleeding visible

A
FBC
U+Es
Clotting
LFTs
Colonoscopy or flexible sig
Rectal exam
Stool cultures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Causes of occult GI bleeding

A
Coeliac disease
Gastric cancer
Peptic ulcer disease
Colorectal cancer
IBD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Management of occult GI bleeding

A

Treat underlying cause.
Replace iron stores if deficient.
Check blood count after 1 month to see if it improves.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Signs, symptoms and deficiency states for fat soluble vitamins

A

A
- Night blindness

D

  • Osteomalacia
  • Proximal limb weakness

E
- Anaemia

K

  • Clotting deficiency
  • Bruising
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Signs, symptoms and deficiency state for vitamins B6, B12, C and folate

A

B6

  • Dermtitis
  • Anaemia

B12

  • Pernicious anaemia
  • Tired/fatigue/pale
  • Peripheral neuropathy

Folate

  • Megaloblastic anaemia
  • Tired/fatigue/pale

C

  • Scurvy
  • Bruising
  • Gingivitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Reasons for malnutrition in hospitals

A

Secondary to pathological disease - raised metabolic demand

Neglect - by patient or staff

NBM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Who should receive nutritional support in hospitals?

A
  • BMI < 18.5
  • Unintentional weight loss >10% in 3-6 months.
  • BMI < 20 and unintentional weight loss >5% in 3-6 months.
  • Eaten little or nothing for 5 days and not likely to in next 5 days.
  • Poor absorptive capacity.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Methods of enteral feeding

A

Oral - supplementation e.g, fortisips.

Tube feeding - NG tube if inadequate or unsafe oral intake.

Enterostomy feeding - if for over 4-6 weeks.

PEG tube - can get perforation, infection or peritonitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Parenteral feeding

A

Only if other routes not suitable e.g. perforated GI tract.

If short term can use peripheral cannula <14 days.

If not the PICC line.

Complicated by thrombophlebitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Refeeding syndrome

A

Complication from too rapid reintroduction of feeding following starvation.

Process:

  • Low insulin levels secondary to starving.
  • When feeding restarted, increased insulin.
  • Insulin causes cellular uptake of phosphate
  • Low phosphate causes respiratory/cardiac failure, muscle weakness, seizures, coma.

Usually occurs in day 4 of refeeding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Which patients are at high risk of refeeding syndrome?

A

BMI < 16

History of alcohol abuse

Little or no intake for 10 days

Low levels of phosphate, potassium or magnesium prior to feed

Unintentional weight loss of >15% in last 3-6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Clinical features of malabsorption

A
Diarrhoea
Steatorrhoea
Weight loss
Fatigue
Flatulence and abdominal distension
Oedema from hypoalbuminaemia
Bleeding disorders (vit K)
Metabolic defects in bones
Neurological manifestation (low Ca, Mg - tetany)
Orthostatic hypotension
Decreased subcut fat
Signs of muscle loss or wasting
Hyperactive bowel sounds
Ascites
Pallor
Peripheral oedema
Glossitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Causes of microcytic hypochromic anaemia

A

LISTS:

Lead poisoning

Iron-deficiency - blood loss, increased demand (growth and pregnancy), decreased absorption (post-gastrectomy, Crohn’s), poor intake.

Sideroblastic

Thalassemia

Sickle cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Causes of normocytic normochromic anaemia

A

HAHAC:

Haemolytic
Acute blood loss
Hypersplenism
Aplastic – bone marrow infiltration
CKD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Causes of macrocytic anaemia

A

PPMATRC:

Pregnancy

Pernicious – intrinsic factor def leading to B12 deficiency

Megaloblastic – B12 / B9 deficiency:
B12 - gastrectomy, ileal disease, resection.
B9 - alcohol, coeliac, Crohn’s, partial gastrectomy, cancer, drugs.

Alcoholism

hypoThyroidism

Reticulocytosis

Cirrhosis – liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Clinical features of anaemia

A
Fatigue
Headache
Angina
Breathlessness
Pallor
Palpitations
Tachycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Epidemiology of coeliac disease

A

Increased in females (2 to 1)

Age peaks in early childhood and again 40-50

1-2% prevalence

FHx - HLA DQ2

RF - other autoimmune disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Signs and symptoms of coeliac disease

A
Tiredness, malaise.
GI symptoms may be absent or mild.
Diarrhoea or steatorrhoea.
Abdominal pain diffuse.
Weight loss.

Mouth ulcers.
Angular stomitis.
Anaemia/pallor.
Dermatitis herpetiformis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Subgroups of coeliac disease

A

CLASSIC - 50%
Typical symptoms

ATYPICAL
Lacks GI symptoms but presents with deficiency state or extra intestinal features

SILENT - 20%
No signs of symptoms

NON-RESPONSIVE

REFRACTORY - 1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Pathophysiology of coeliac disease.

A

Proteins in wheat, barley, rye are broken down by tissue transglutaminase into GLIADIN.

Gliadin then presents to T cells via HLA class 2 DQ2 and DQ8.

T cells produce inflammatory cytokines.

Over expression of IL 15
47.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Investigations for coeliac disease

A

IgA anti-tissue transglutaminase antibodies - highly specific and sensitive. They become undetectable after 6 months of a gluten free diet.

FBC - microcytic anaemia from iron deficiency
Howell-Jollie bodies (leukocytes).

LFTs - raised transaminases.

Small bowel biopsy is gold standard - need to still be consuming gluten.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Treatment of coeliac disease

A

GLUTEN FREE DIET!

NHS can subsidise gluten free products.

Recommended to have 5 yearly pneumococcal vaccinations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Hernias - most to least common

A

Inguinal (indirect or direct).

Femoral.

Umbilical and para-umbilical.

Incisional.

Ventral and epigastric.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Types of hernias: reducible/irreducible/strangulation.

A

Reducible:

  • Lump disappears lying down, not painful.
  • Cough impulse.

Irreducible:

  • Adhesions to sac wall mass larger than neck not reducible.
  • Cough impulse.

Strangulation:
Contents restricted by neck so circulation is cut off - gangrene inevitable.
- Severe pain, central, colicky.
- Vomiting, distension, constipation (from obstruction).
- Tender, tense.
- No cough impulse.
- Noisy bowel sounds.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Hernias most likely to strangulate

A
  1. Femoral
  2. Indirect inguinal
  3. Umbilical
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Indirect inguinal hernia

A

Pass through internal ring.
Lateral to inferior epigastric vessels.
May be congenital.
Can be controlled by pressure over internal ring.
Commonly strangulates due to narrow neck.
Often extends to scrotum.
Does not readily reduce on lying.

Hernia does not reach full size until the patient has been up for some time, does not reduce on lying

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Direct inguinal hernia

A

Pass through posterior wall of inguinal canal

MEDIAL to inferior epigastric vessels

Always acquired

Not controlled by pressure over internal ring

Rarely strangulate due to wide neck

Reduces spontaneous on lying

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Borders of the inguinal canal

A

Anterior - skin, external oblique aponeurosis

Posterior - conjoint tendon forms posterior well medially, transversalis fascia laterally

Above - internal oblique and transversus abdominis

Below - inguinal ligament

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Describe a femoral hernia (anatomy, epidemiology)

A

Anatomy:

  • Passes through the femoral canal.
  • Medial to the femoral sheath.
  • Femoral sheath contains the femoral artery and vein.

Epidemiology:

  • Females > Males.
  • More common in the middle aged and elderly.
  • Swelling BELOW and LATERAL to pubic tubercle.
  • Enlarges on standing and coughing.
  • DIsappears on lying down.

Strangulation common due to narrow neck.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Exomphalos

A

Rare condition.

Failure of all or part of midgut to return to abdominal cavity in foetal life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Presentation of congenital diaphragmatic hernias.

A

Different types.

In more serious cases, presents as respiratory distress shortly after birth and require urgent surgery.

Other examples: large oesophageal hiatus which present with regurgitation, vomiting, dysphagia and progressive weight loss in the child.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

List the types of acquired hiatus hernias.

A

Sliding (80%)

  • Stomach (GO junction and cardia sometimes) slides through diaphragmatic hiatus.
  • It is covered anteriorly with peritoneal sac, posteriorly with extraperitoneum.
  • It disturbs cardio-oesophageal mechanism.

Rolling (20%)

  • Cardia remains in position.
  • Gastric fundus moves up and lies alongside the GOJ, which creates a bubble of stomach in the thorax.
  • This is a true hernia within a peritoneal sac.
  • No regurgitation symptoms.
  • Represents progressive weakening of hiatus muscles.
  • 4x more common in females.
  • Occurs in obese, middle aged and elderly.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Presentation of acquired hiatus hernia.

A
Cough.
Dyspnoea.
Palpitations.
Hiccoughs.
Retrosternal burning.
Pain worse on lying and swooping.

Occult bleeding from oesophagitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Treatment of hiatus hernias.

A

Treat symptomatically.

If unsuccessful, laparoscopic repair indicated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Epidemiology of colon cancer.

A

Epidemiology:

  • 50 per 100,000.
  • 3rd most common malignancy.
  • Risk increases with age.
  • Males > Females.
  • FHx (HNPCC, FAP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Risk factors of colon cancer.

A

Risk Factors:

  • UC or Crohn’s
  • Pelvic radiotherapy
  • Smoking
  • Alcohol
  • Obesity
  • Sedentary lifestyle
  • Red meat
  • DMII
  • Aspirin/NSAIDs
  • Cholecystectomy
  • Low fibre diet
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Gram-negative, oxidase positive, non-lactose fermenting bacilli.

A

Pseudomonas aeruginosa.

This bacterium can cause a range of infection such as pneumonia, urinary tract infections and skin infections amongst others.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Gram-negative, maltose-utilising diplococci

A

Neisseria meningitidis

Which is mostly known for causing meningitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Gram-negative, oxidase positive, growth at 42 C, comma-shaped rods

A

Vibrio cholerae

Which can cause severe rice-water diarrhea in places where water has been contaminated with the organism.

Dehydration and electrolyte imbalance is a common cause of death, and therefore proper hydration is vital to prevent death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

Gram-negative, oxidase positive, catalase positive comma-shaped rods

A

Helicobacter pylori

Which causes chronic gastritis and peptic ulcer disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Gram-positive, urease positive, catalase positive cocci

A

Staphylococcus epidermidis

Which is part of the normal skin flora but can also be responsible for infection of catheters and other devices such as mechanical heart valves.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

Gram-positive, catalase positive cocci

A

Staphylococcus bacteria

Which can further be differentiated based on the coagulase positivity and novobiocin sensitivity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

Gram-positive aerobic bacilli

A

Listeria, Bacillus and Corynebacterium bacteria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

Gram-negative, oxidase-positive comma-shaped rods

A

Campylobacter jejuni which grows at 42 degrees celcius,

Vibrio cholerae which grows in alkalin media

Helicobacter pylori which produces urease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Gram-negative, maltose-utilising diplococci

A

Neisseria meningitidis bacteria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Tumour marker of colonic cancer

A

Carcinoembryonic antigen (CEA)

Note: Screening for colonic cancer using CEA is not justified!

It is falsely elevated in a number of non-malignant disease states such as cirrhosis and colitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

Metoclopramide (antiemetic) is contraindicated in which disease?

A

Parkinson’s disease (PD)

Metoclopramide is a dopamine antagonist which can make the symptoms of PD worse. There is a degeneration of the basal ganglia in PD and a lack of dopamine. Further inhibiting the action of dopamine increases the symptoms of PD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

Carcinoid tumour markers?

A

Urinary 5-HIAA

Plasma chromogranin A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

Causative organism that causes fat malabsorption, therefore greasy stool can occur.

It is resistant to chlorination, hence risk of transfer in swimming pools.

A

Giardia lamblia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

Which bacteria is seen with antibiotic use?

A

Clostridium difficile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

Borders of the femoral canal?

A

Laterally - Femoral vein

Medially - Lacunar ligament

Anteriorly - Inguinal ligament

Posteriorly - Pectineal ligament

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

Types of shock

A
Septic
Haemorrhagic
Neurogenic
Cardiogenic
Anaphylactic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

Hesselbach’s triangle boundaries?

Note:
Direct hernias pass through Hesselbachs triangle.

A

Superolaterally - Epigastric vessels

Medially - Lateral edge of rectus muscle

Inferiorly - Inguinal ligament

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

Most common complication of endoscopic retrograde cholangiopancreatography (ERCP)?

A

Acute pancreatitis is the most common complication of ERCP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Linitis plastica

A

Linitis plastica produces a diffuse infiltrating lesion, the stomach is fibrotic and rigid and will not typically distend.

This may be described as a ‘leather bottle stomach’.

Diagnosis is made with a combination of pathology examination with endoscopy, radiological or surgical assessment.

Pathologically signet-ring cell proliferation occurs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Indirect inguinal

A

Indirect inguinal hernia is lateral to epigastric vessels

Indirect inguinal hernias occur due to failure of the processus vaginalis to regress.

The protrusion occurs through the deep inguinal ring and enters the inguinal canal.

It may progress and enter the scrotum in males or labia in females.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Sulphasalazine important side effect.

A

Sulphasalazine can cause oligospermia and infertility in men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Aminosalicylate drugs

A

5-aminosalicyclic acid (5-ASA) is released in the colon and is not absorbed. It acts locally as an anti-inflammatory. The mechanism of action is not fully understood but 5-ASA may inhibit prostaglandin synthesis

Sulphasalazine
a combination of sulphapyridine (a sulphonamide) and 5-ASA
many side-effects are due to the sulphapyridine moiety: rashes, oligospermia, headache, Heinz body anaemia, megaloblastic anaemia, lung fibrosis
other side-effects are common to 5-ASA drugs (see mesalazine)

Mesalazine
a delayed release form of 5-ASA
sulphapyridine side-effects seen in patients taking sulphasalazine are avoided
mesalazine is still however associated with side-effects such as GI upset, headache, agranulocytosis, pancreatitis*, interstitial nephritis

Olsalazine
two molecules of 5-ASA linked by a diazo bond, which is broken by colonic bacteria

*pancreatitis is 7 times more common in patients taking mesalazine than sulfasalazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

Metoclopramide

A

Metoclopramide is a D2 receptor antagonist mainly used in the management of nausea. Other uses include:
gastro-oesophageal reflux disease
prokinetic action is useful in gastroparesis secondary to diabetic neuropathy
often combined with analgesics for the treatment of migraine (migraine attacks result in gastroparesis, slowing the absorption of analgesics)

Adverse effects
extrapyramidal effects: oculogyric crisis. This is particularly a problem in children and young adults
hyperprolactinaemia
tardive dyskinesia
parkinsonism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

List 2 opioid agonists used as antidiarrhoeal agents.

A

Loperamide
Diphenoxylate

They act on u-opioid channels in GIT.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

Clinical features of colon cancer

A

Dependent on site of cancer

Left:

  • Fresh rectal bleeding
  • Early obstruction
  • Tenesmus
  • Mucus (if rectal)
  • Early change in bowel habit
  • Mass in LIF

Right:

  • Anaemia from occult bleeding
  • Altered bowel habit
  • Mass in RIF

Colicky pain

Weight loss

Obstruction or perforation

Hepatomegaly/ascites if mets

Peritonitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

Signs of peritonitis

A

Rock hard abdomen
Rebound tenderness
Absent bowel sounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

Most common places for bowel cancer?

A

Rectosigmoid 45%
Ascending colon 30%
Descending colon 15%
Transverse colon 10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

Pathophysiology of colon cancer

A

Malignant transformation of benign adenomatous polyp.

Accumulation of multiple genetic mutations:

  • APC gene
  • K-ras gene - failure leads to cell proliferation
  • DCC gene - has a role in invasion and metastasis
  • p533 gene - role in impaired apoptosis and cell proliferation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

HNPCC
Hereditary non-polyposis colon carcinoma
Also known as Lynch syndrome

A

Occurs at a young age with family history
- autosomal dominant
Mean age 45, lifetime risk 80%

It is the most hereditary syndrome
Majority occur proximally

Increased risk of other cancers: endometrium, ovary, urinary tract, stomach, small intestine, pancreas, CNS

Regular colonoscopy every 1-2 years from 25

Criteria for diagnosis - 3+ relatives with colon cancer (1 must be 1st degree, must be across 2 generations) & 1 family member affected under 50, FAP excluded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

FAP

Familial adenomatous polyposis

A

Hereditary disorder causing numerous polyps and resulting in colon carcinoma before 40
Autosomal dominant

Patients usually asymptomatic
Diagnosis by colonoscopy (100+ polylps) and genetic testing (APC gene)

Treated with colectomy
Polyps present in 50% by 15 and 95% by 35

Extra intestinal manifestations:

  • osteoma of skull/mandible
  • sebaceous cysts
  • increase in cancer: small intestine, pancreas, thyroid, brain, liver and gastric cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

Treatment of colon cancer

A

Surgery - without metastatic disease.

  • Tumour + resection margins + pericolic lymph nodes removed.
  • Reanastamose or stoma

Adjuvant therapy =
- If lymph spread it can’t be controlled with surgery alone
Chemotherapy with 5-FU or carbecitabine or irinotecan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

Investigations for colon cancer

A

FBC - anaemia
LFTs - for mets
Colonoscopy for diagnosis + biopsy (GOLD STANDARD)
CT colongraphy

CT or MRI and liver US for staging
PET for recurrent but not initial cancer

CEA is raised in colon cancer but is not useful for screening. Good prognostic factor, better outcome if CEA negative,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

Screening for colon cancer

A

Faecal occult blood

Every 2 years after 60

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

When to refer for suspected bowel cancer?

A

> 40 + rectal bleeding + loose stools for over 6 weeks

> 60 with rectal bleeding OR loose stools >6 weeks regardless of other symptoms

If right lower abdominal mass consistent with large bowel

Palpable rectal mass (NOT pelvic - urology or gynae referral)

Men with unexplained iron deficiency anaemia <11

Non-menstruating women with unexplained iron deficiency anaemia <10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

Staging for bowel cancer

A
Dukes
A - tumour confined to bowel (10%)
B - extension through bowel wall (35%)
C - tumour involving lymph nodes (30%)
D - distant mets (25%)

Or can use TNM

T - 1 submuscosa, 2 muscularis propria, 3 pericolorectal tissues, 4A surface of visceral peritoneum, 4B directly invades

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

Symptoms of peritonitis

A
Abdominal pain **
Localised pain if contained, generalised after rupture
Anorexia
Nausea
Vomiting
Fever and chills
Diarrhoea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

Signs of peritonitis

A

High fever in early stages
Rebound tenderness
Absent bowel sounds
Rock hard abdomen

Guarding and rigid abdomen
Hypotensive
Signs of septic shock
DRE increases abdominal pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

Aetiology of primary peritonitis

A

Spontaneous bacterial peritonitis is acute bacterial of infection of ascitgic fluid resulting from translocation ofbacteria across gut wall

Complications of ascites

90% is mono-microbial

40% E.coli, 7% Klebsiella pneumonia, 15% strep 30%
Predominantly gram negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

Aetiology of secondary peritonitis

A

Pathogens depend on location in GI tract

Mainly gram positive in upper GI tract

Colon perforation generally multi-microbial and predominantly gram negative

All caused by perforation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

Causes of peritonitis

A
Malignancy
Penetrating trauma
Ulcer perforation
Stone perforation
Iscahemic bowel
Bowel obstruction 
Crohn's
Appendicitis
Post-operative 
Peritoneal dialysis
Pancreatitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

Investigations for peritonitis

A

FBC - raised WBC, CRP
LFTs, amylase and lipase for pancreatitis
Blood cultures - sepsis
Peritoneal fluid for culture
Urinalysis to rule out urinary tract pathology
Abdominal x=ray
CT/MRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

Treatment for peritonitis

A

Correction of underlying pathology
Systemic antibiotics
Supportive therapy to prevent organ system failure
Antibiotics are dependent on the cause - usually 3rd generation cephalosporin

Haemodynamic, pulmonary and renal support = fluid resuscitation, monitor renal function, blood gases, urine output, BP, HR

Nutrition support - high requirement in sepsis

Surgery to correct pathology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

Describe pain coming from fore, mid and hindgut

A

Foregut = stomach, duodenum, liver, pancreas. Pain described as upper abdominal pain.

Midgut = small bowel, proximal colon and appendix. Pain felt in umbilicus

Hindgut = distal colon and genito-urinary tract. Lower abdominal pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

Causes of diffuse abdominal pain

A
Pancreatitis 
Diabetic ketoacidosis
Early appendicitis
Gastroenteritis
Intestinal obstruction
Mesenteric ischaemia
Peritonitis
Sickle cell anaemia crisis
Spontaneous bacteria peritonitis
Typhoid fever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

Red flags for abdominal pain

A
Severe pain
Tachycardia
Hypotension
Confusion
Signs of peritonitis
Abdominal distension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

Causes of RUQ pain

A
Appedicitis with gravid uterus
Cholecystitis
Biliary colic
Congestive hepatomegaly
Hepatitis
Perforated duodenal ulcer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

Causes of RLQ pain

A

Appendicitis
Caecal diverticulitis
Merkel diverticulitis
Mesenteric adenitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

Causes of lower abdominal pain - R or L

A
Abdominal or psoas abscess
Abdominal wall haematoma
Cystitis
Endometriosis
Strangulated hernia
IBD
PID
Renal stone
Ruptured AAA
Ectopic pregnancy
Ovarian cyst torsion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

Define diarrhoea

A

Passage of >200g of stool per day

Can be acute or chronic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

Categories of diarrhoea

A

OSMOTIC

  • when unabsorbable water solutes remain in the bowel and retain water
  • Stops with fasting
  • Examples: sorbitol, malabsorption causing high concentration in lumen, absorptive defect e.g. lactase deficiency

SECRETORY

  • Bowel secretes more electrolytes and water
  • Persists with fasting
  • Causes: infection, malabsorption. drugs (colchicine, quinine), endocrine tumours
  • Enterotoxins cause block of Na/H+ exchange or absorption of Cl-

INFLAMMATORY

  • reduced surface area or contact time
  • Causes: bowel resection, IBD, Coeliac, shigella
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

Causes of acute diarrhoea

A

Likely to be infective

bacteria: salmonella, campylobacter, shigella, E.coli, C. Diff. bacillus cereus
viral: norovirus, rotavirus, CMV, hep A
parasite: giardia,

Drugs: antibiotics, cytotoxic drugs, PPIs, NSAIDs

Ask about recent travel abroad

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

Causes of chronic diarrhoea

A
IBS
IBD
Bowel resection
Coeliac disease
Pancreatic insufficiency
Lactose intolerance
Colon cancer
Lymphoma
Hyperthyroidism
Diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

Red flags for diarrhoea

A
Blood
Pus
Fever
Signs of dehydration
Chronic
Weight loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

Management of acute diarrhoea

A
  1. Enquire about red flag symptoms
  2. Assess for dehydration
  3. Offer Oral rehydration therapy - 100ml per episode. if sever then IV 5% dextrose
  4. Stool cultures
  5. Faecal examinati0on for parasites and ova
  6. Faecal alpha 1 antitrypsin levels - high in entroinvasive infections usually self-limiting

Only requires supportive treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

Causes of constipation

A
  • lack of fibre or fluid intake
  • immobility
  • old age
  • bowel obstruction: volvulus, adhesions, hernia, faecal impaction, strictures
  • IBS
  • Drugs: opiates, anti-cholinergic, calcium antagonists, iron supplements, anatacids, antipsychotics, antispasmodics, general anaesthetics
  • Colon cancer
  • Obstruction: strictures, Crohn’s, pelvic mass
  • Metabolic/endocrine: hypothyroid, hypercalcaemia, hypokalaemia
  • Neuromuscular: spinal or pelvic nerve injury, diabetic neuropathy
  • Parkinsonism
  • Diabetes
  • Pregnancy
  • Depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
118
Q

Red flags for constipation

A
Distended abdomen
Vomiting
Blood in stool
Weight loss
Severe constipation with recent onset or worsening
Over 50
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
119
Q

Investigations for constipation

A

Blood tests
FBC, U&E, TFTs, calcium
Blood glucose

Abdominal X-ray for masses or obstruction

PR exam

Barium enema or colonoscopy/sigmoidoscopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
120
Q

Rome III criteria for functional constipation

A

Functional constipation. must include 2 or more of:

  • straining
  • lumpy/hard stools
  • sensation of incomplete evacuation
  • Sense of anorectal obstruction
  • Manual manoeuvres
  • Less than 3 per week

Each symptom must be present >25%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
121
Q

Bristol Stool Chart

A
  1. Separate hard lumps
  2. Lumpy sausage shape
  3. Like sausage with cracks
  4. Sausage, smooth and soft
  5. Soft blobs with clear cut edges
  6. Fluffy with ragged edges (mushy)
  7. Watery, no solid pieces
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
122
Q

Management of constipation

A

INITIAL if no alarm

  • Patient education
  • High fibre diet
  • Increase fluids
  • Increase exercise
  • Bulk laxatives
  1. Bulk laxatives e.g. ispaghula husk
  2. Osmotic or stimulant laxatives
  3. Refer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
123
Q

Symptoms of IBS

A

6 month history of either: abdominal pain or discomfort, bloating or change in bowel habit

  • Pain improves in defaecation
  • Altered passage of stool: straining, urgency, incomplete evacuation
  • Abdominal bloating
  • Distention
  • Symptoms aggravated by eating
  • Rectal mucus
  • lethargy
  • Nausea
  • Backache
  • Urinary frequency and urgency
  • Headaches and migraine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
124
Q

Epidemiology of IBS

A

10-20% of population
Increased in women (2:1)
Peak between 20-40

RF
Emotional stress
Food poisoning or gastroenteritis
Mental health condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
125
Q

Criteria for IBS

A

Rome III Criteria

Recurrent abdominal pain for over 3 months, at least 3 days per month, PLUS 2 or more of:

  • Pain improves with defaecation
  • Change in stool frequency
  • Change in stool form
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
126
Q

Pathophysiology of IBS

A

Psychological factors, altered GI motility, altered visceral sensation

7-30% develop IBS following gastroenteritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
127
Q

Investigations for IBS

A
FBC, ESR, CRP
Coeliac screen
CA-125 if ?ovarian cancer
Faecal calprotectin if ?IBD
Colonoscopy or sigmoidoscopy
Refer if any RED FLAGS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
128
Q

Classification for IBS

A

IBS-C - constipation - loose stool <25%, Hard stools >25%
IBS-M - mixed - both hard and soft stools >25% of the time
IBS-D - diarrheoa - loose stool >25%, hard <25%
104

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
129
Q

Treatment of IBS

A

Constipation
- high fibre diet, bulk forming laxatives (ispaghula husk) or osmotic (but avoid lactulose)

Diarrhoea
- reduce fibre + loperamide, codeine, colestyramine

Pain and bloating - use spasmolytic drugs e.g. amitryptiline

Treat the symptoms of the patient

CBT, hypnotherapy, psychotherapy

130
Q

Symptoms of achalasia

A
Dysphagia
Affecting solids more than liquids
Regurgitation in 80%
Chest pain in 50% - occurs after eating, retrosternal
Heartburn is common
Weight loss suggests malignancy
Nocturnal cough
No signs!
131
Q

Pathophysiology of achalasia

A

Smooth muscle layer of oesophagus has impaired peristalsis and failure of the sphincter to relac causes functional stenosis or stricture

Most have no underlying cause

132
Q

Investigations for achalasia

A

CXR - vastly dilated oesophagus

Barium swallow - usually precedes endoscopy when investigating dysphagia as can perforate malignancy with endoscope.
Birds beak - narrow segment in distal oesophagus.

Endoscopy

Manometry - is GOLD STANDARD - can detect 90% of cases. High resting pressure in cardiac sphincter, incomplete relaxation on swallowing and absent peristalsis

If no radiological evidence - it may be pseudoachalasia

133
Q

Management of achalasia

A

Calcium channel blockers and nitrates - reduce pressure in lower sphincter. Only works in 10%

Heller myotomy - divide muscles longitudinally (90% success)

Pneumatic dilation - balloon inflated to rupture muscle, leaving mucosa intact

Enodscopic injection of botulinum but recurs in the majority.

Endoscopic stent insertion

134
Q

Causes of dysphagia

A
Benign stricture: schataki ring, GORD
Malignant stricture: SCC, adenocarcinoma
Stroke
Achalaisa
Parkinson's
Motor neurone disease
Myasthenia gravis
135
Q

Epidemiology of oesophageal cancer

A

13th most common in the UK, 8th most common worldwide
Increased in age - most are over 60
Increased in men
High in East African and Asia
Increasing prevalence of adenocarcinoma, decreasing SCC

RF
Adenocarcinoma:
- Caucasian
- Barrett's oesophagus
- Obesity

SCC:

  • Achalasia
  • Corrosive strictures
  • Coeliac
  • African

Both

  • Smoking
  • Alcohol
  • Radiation to area
  • Genetics
  • Diet (high sat fat)
136
Q

Symptoms of oesophageal cancer

A
Dysphagia (initially liquids then solids)
Vomiting
Anorexia
Weight loss
Blood loss/ melaena
Odynophagia (painful swallowing)
Hoarseness
Retrosternal or epigastric pain
Persistent cough
Lymphadenopathy
137
Q

Types of oesophageal cancer

A

Adenocarcinoma - more common in lower oesophagus. Mainly progression from Barrett’s oesophagus

Squamous cell carcinoma - can be anywhere along the oesophagus

138
Q

Investigations for oesophageal cancer

A

FBC - anaemia
U&Es, LFTs for baseline
CRP - can be raised
Glucose

Urgent endoscopy and biopsy

CXR for mets and spread

Double contrast barium swallow

Staging - FDG PET/CT or MRI

Endoscopic Ultrasound

139
Q

Prognosis of oesophageal cancer

A

50% have mets at diagnosis
presents late as 75% of lumen needs to affected around the circumference before difficulties present

20-25% 5 year survival rate

AC and SCC have the same prognosis

140
Q

Management of oesophageal cancer

A

Primary = surgery +/- chemo +/- radiotherapy

Surgery

  • antibiotic and antithrombotic prophylaxis given
  • If early, endoscopic muscosal resection
  • If late: oesophagectomy endoscopically if possible
  • Abdominal lymphadenectomy is beneficial
  • Chemo and radiotherapy shrink tumour prior to resection

Palliative

  • Can use chemo/radiotherapy to decrease bulk
  • Fit stent to allow swallowing
  • PEG for feeding
  • ANALGESIA
141
Q

Epidemiology of GORD

A

25% of adults, 5% have daily symptoms

More common in men

142
Q

Risk factors of GORD

A
  • Obesity
  • Pregnancy
  • Systemic sclerosis
  • Drugs: nitrates, TCAs, anticholinergics, calcium channel blockers
  • Hiatus hernia
  • Increased intra abdominal pressure
  • Smoking
  • Alcohol
  • Large meals
143
Q

Symptoms of GORD

A
Heartburn worsened on lying or bending down
Retrosternal discomfort
Regurgitation
Pain on swallowing
Nocturnal cough
Excessive salivation
Chronic hoarseness
Acid brash
Pain relieved by antacids

No signs

144
Q

Endoscopic findings in GORD

A

60-70% have normal endoscopy (non-erosive reflux disease)
20-30% erosive oesophagitis
6-10% Barrett’s oesophagus

Can show basal hyperplasia, inflammation, Goblet cell metaplasia, thinning of squamous layer or dysplasia

145
Q

Pathophysiology of GORD

A

Spectrum of disorders from endoscopy negative GORD to oesophageal damage

3 main causes:

  • Poor oesophageal motility
  • Dysfunction of lower oesophageal sphincter (permanent or intermittent relaxation or increase in abdominal pressure)
  • Delayed gastric emptying
146
Q

Investigations for GORD

A

FBC to exclude anaemia
H.pylori stool test (stool antigen test)
Endoscopy +/- biopsy (must be drug free for 2 weeks)
Barium swallow

147
Q

Management of GORD

A

Assess for possibility of GI bleed

Simple lifestyle advice: healthy eating, weight reduction, smoking cessation.

Avoid precipitants: smoking, alcohol, coffee, chocolate, fatty foods, acidic foods e.g. tomatoes, oranges

Raised head of bed

Avoid eating late at night

If H.pylori positive, treat

Full dose PPI for 4 weeks.
Can offer H2 receptor agonist therapy as alternative.
Antacids as required

If very severe and uncontrollable, can fit magnetic band around LOS to aid closure.

148
Q

Urgent referral criteria for GORD

A

Dysphagia

Dyspepsia + weight loss/anaemia

Dyspepsia new onset in over 55s

Dyspepsia plus one of:

  • FHx of upper GI cancer
  • Barrett’s
  • Pernicious anaemia
  • upper abdominal mass
  • known dysplasia
149
Q

Complications of GORD

A
Oesophagitis
Ulceration
Anaemia
Stricture
Barrett's oesophagus
150
Q

What is Barrett’s oesophagus

A

Premalignant condition
Normal squamous lining is replaced by columnar cells
Adaptive response to GORD

151
Q

Classification of GORD

A

Savary-Miller Grading system

  1. single or multiple erosions on single fold
  2. multiple on multiple folds
  3. multiple circumferential erosions
  4. ulcers, stenosis or oesophageal shortening
  5. Barrett’s

Can use Los Angeles Grades A-D

152
Q

Epidemiology of peptic ulcer disease

A

Of the 1% with reflux receiving endoscopy, 13% will have peptic ulcer disease
1 per 1000 (0.1%)
Decreasing in Western populations
Increased in males

RFs

  • Smoking
  • Alcohol
  • NSAID or steroid use
153
Q

Symptoms of peptic ulcer disease

A
Post-prandial epigastric pain
Relieved by food
Nausea
Oral flatulence
Bloating
Intolerance of fatty foods
Heartburn
Pain can radiate to the back if ulcer is posterior
Fatigue or dyspnoea if anaemia
melena

Signs
Epigastric tenderness

154
Q

Aetiology of peptic ulcers

A
H. pylori
Bile acids
NSAIDs
Steroids
pepsin
Stress
Smoking
Changes in mucus consistency
Alcohol
155
Q

Pathophysiology of H.pylori

A

Gram negative spiral

Lives deep beneath mucus layer

Closely adheres to epithelial surface

Uses an adhesin (BabA)

Any acidity is buffered by urease

156
Q

Pathophysiology of peptic ulcers

A
  1. Depletion of somatostatin
  2. Increase gastrin release from G cells
  3. Increased acid secretion
  4. Increased acid load in duodenum will cause metaplasia
157
Q

Investigations for peptic ulcer disease

A

FBC - iron deficiency anaemia

H. pylori test - 13C breath test or stool antigen test

Endoscopy if there are any warning signs

158
Q

Complications of peptic ulcers

A

Perforation (more common in duodenal)
Gastric outlet obstruction
Bleeding
Anaemia

159
Q

Treatment of H. pylori

A

TRIPLE therapy for 7 days

Clarithromycin
PPI
Amoxicillin or metronidazole

160
Q

Treatment of peptic ulcers

A

Lifestyle advice: stop smoking and alcohol

If H.pylori positive treat
If taking NSAIDs = STOP

If neither is positive (rare), endoscopy for ? Zollinger-Ellison syndrome

Endoscopic ablation if actively bleeding

161
Q

Functional dyspepsia

A

Chronic discomfort in the upper abdomen without any organic disease (as seen in GORD)

Drug treatment not useful.
Prokinetic drugs e.g. metoclopramide may be helpful

162
Q

Define cholelithiasis

A

Cholelithiasis: formation of gallstones within the gallbladder

163
Q

Define choledolithiasis

A

Choledocholithiasis: stones in the common bile duct

164
Q

Epidemiology of gallstones

A

10-15% of Western population but only 10-25% of these become symptomatic
Increases with age
Increased in women
increased in middle age

Fair, fat, fertile, female and 40

RF
FHx
Obesity
Pregnancy
Sudden weight loss
Haemolysis (sickle cell)
Loss of bile salts (ileal resection)
Drugs (oestrogens, fibrates, somatostatin)
Diabetes
Oral contraception
Crohn's
165
Q

Symptoms of gallstones

A

70% are asymptomatic
Pain in RUQ or epigastrium, can radiate to the back
Pain begins post-prandially
Pain is intense and dull
Subsides spontaneously, after analgesia, vomiting, antacids, defaecation, flatus or positional changes
Sporadic and unpredictable episodes
Persists from 5 minutes to 24 hours
Nausea or vomiting can accompany pain
Intolerances to fats
Abdominal distension
Can have diaphoresis (excessive sweating)

166
Q

Signs of gallstones

A

No findings if asymptomatic
Tachycardia (due to pain)
No peritoneal signs
If complications: can have jaundice, positive Murphy’s sign or pancreatitis

167
Q

Types of gallstones

A

Cholesterol stones (80%)
Large, solitary and radiolucent
Increased with increased cholesterol

Pigment stones (20%)
Small, black and friable, irregular radiolucent
RFs - haemolysis and cirrhosis
Occurs with high levels of unconjugated bilirubin
Calcium bilirubinate can crystalise to form stones

Mixed stones - calcium salts, pigment and cholesterol, 10% are radio-opaque

Brown pigment stones <5%, due to stasis and generally present with E.coli or Klebsiella infection

168
Q

4 stages of gallstone formation

A
  1. Lithogenic state in which conditions favour gall stones: high cholesterol, low bile sales
  2. Asymptomatic gallstones
  3. Symptomatic gallstones with episodes of biliary colic
  4. Complicated cholethiasis
169
Q

Investigations for gallstones

A

Blood tests: FBC, LFTs, amylase and lipase
If uncomplicated or simple biliary colic, will be normal

Abdominal x-ray to rule out obstruction

US - best way to see stones. They are usually echogenic, mobile and cast an acoustic shadow.

ERCP - can be used to see and remove stones in CBD

MRCP - using MRI, reserved for suspected choledolithiasis.

170
Q

Management for gallstones

A

Manage with pain with morphine
Laparoscopic cholecystectomy
If unfit for surgery can surgical drain the gallbladder (cholecystotomy)

If stones in bile duct then - cholecystectomy and CBD exploration and stone extraction

Consider mechanical or shock wave lithotripsy

If asymptomatic watch and wait.

171
Q

Reasons for cholecystectomy in asymptomatic patients

A

Stone > 2cm

High risk of GB carcinoma

Non-functioning GB

Sensory neuropathy of abdomen

Sickle cell anaemia

Cirrhosis or portal hypertension

Children

Transplant candidates

Diabetics

172
Q

Complications of gallstones

A

Cholangitis if in biliary tree

GB empyema

Gallstone ileus

Fibrosis of gallbladder

Loss of gallbladder function

GB carcinoma

173
Q

Epidemiology of cholecystitis

A
10% have gallstones
1/3 get cholecystitis
Increases with age
increased in females
Although acalculus is more common in men
RFs
Gallstones
Trauma
Obesity
Rapid weight loss
Pregnancy
Crohn's
Hyperlipidaemia
RF for acalculus
Major surgery
Long term parenteral nutrition
Sepsis
Prolonged fasting
174
Q

Symptoms of cholecystitis

A

Upper abdominal pain
may radiate to right shoulder or scapula

Pain begins in epigastrium and localises to RUQ

Starts colicky but becomes constant in all cases nausea and vomiting

Fever

175
Q

Signs of cholecystitis

A

Raised WCC

Positive Murphy’s sign

Local peritonism

Fever

Tenderness in epigastrium/RUQ

Tachycardia

Jaundice

Guarding/rebound tenderness palpable GB

176
Q

Pathophysiology of cholecystitis

A

90% are calculous

  • Stone obstructs cystic duct causing distension of GB
  • Blood flow and lymph drainage of the gallbladder are compromise and can cause ischaemia and necrosis

Acalculous 10%

  • Cause unclear.
  • If fasting GB has no CKK stimulus and so bile remains stagnant
177
Q

Causes of cholecystitis

A

GALLSTONES

Acalculus
MI
Sickle cell
Salmonella
Diabetes
AIDS
CMV
pregnancy
178
Q

Investigations for cholecystitis

A

Blood tests -
Raised WCC
Raised ALT and AST
Check amylase and lipase for pancreatitis

Urinalysis to rule out pyelonephritis and renal stones
Pregnancy test

CXR to rule out lower lobe pneumonia or see radiopaque stones

US - thickened gall bladder wall >3mm, pericholecystic fluid or air on GB or GB wall

CT with IV contrast

179
Q

Treatment for cholecystitis

A
Rest
IV hydration
Bowel rest - no intake
Correct electrolyte imbalance 
Analgesia
IV antibiotics (tazocin/metronidazole)
Laparoscopic cholecystectomy
ERCP
180
Q

Triad of ascending cholangitis

A

Charcot’s triad
RUQ pain
Jaundice
Fever

Reynold’s pentad adds confusion and hypotension

181
Q

Cholangitis

A

Infection of biliary tract
Majority of cases are due to gall stones

10-30% are due to benign strictures, post-op damage, tumours, bacteria (anaerobes) and parasites

Carries significant risk of death due to shock or multi organ failure

182
Q

Blood test results in cholangitis

A
Raised CRP or WCC
Increased LFTs (ALP, AST, ALT, GGT)
183
Q

Epidemiology of gastric cancer

A

8th most common cancer
Increases in Asia and South America
Increases with age
More common in men

50% in pylorus, 25% in lesser curve, 10% cardia, 2-8% lymphomas

184
Q

Pathophysiology of gastric cancer

A

Correa’s cascade

  • Chronic non-atrophic gastritis
  • Atrophic gastritis
  • Intestinal metaplasia
  • Dysplasia
  • Cancer

Can spread to ovaries

2 main types:

  • Intestinal (type 1) with well formed glandular structures. Ulcerating lesions with heaped rolled edges. Strong environmental association
  • Diffuse (type 2) poorly cohesive cells. Poorer prognosis. Loss of expression of E=cadherin molecule
185
Q

Investigations for gastric cancer

A

FBC for anaemia
LFTs

Rapid access flexible endoscopy: Gastroscopy and biopsy

Endoscopic US for local staging and depth

Chest/Abdo/Pelvis CT

18F PET/CT

186
Q

Management of gastric cancer

A

Surgery is treatment of choice

  • If distal then subtotal gastrectomy, if proximal then total
  • If curable remove D2 lymph nodes

Perioperative chemotherapy is standard with 5-FU, but can be palliative

Blood transfusion if anaemia

Corticosteroids for management of anorexia

187
Q

Prognosis of gastric cancer

A

Overall survival rate 15%
11% live 10 years

Younger patients have a better prognosis

Poorer prognosis if paraneoplastic syndrome

188
Q

Risk factors of gastric cancer

A
H.pylori infection
Smoking
Diet: rich in pickles, salt, smoked meats and fish
FHx
Poor socioeconomic status
Previous gastric surgery
Obesity
189
Q

Epidemiology of pancreatitis

A

150 per million
3% of all abdominal pain in hospital
High in USA & Scandinavia
Equal gender distribution

190
Q

Risk factors of pancreatitis

A
  • Alcohol abuse
  • Some family history (alpha 1 antitrypsin deficiency)
  • Hyperlipidaemia
  • Gallstones
  • CF
  • Smoking
  • Oestrogens
  • Hypothermia
  • Congenital abnormalities
  • Vasculitis
191
Q

Symptoms of acute pancreatitis

A

Severe upper abdominal pain

Decreases steadily over 72 hours

Pain focused in LUQ or epigastrium

Penetrates to the back

Sudden onset vomiting

192
Q

Signs of acute pancretitis

A
Mild pyrexia (common), rare but can have hypothermia
Hyperlipidaemia
Tachycardia
Jaundice
Abdominal tenderness and rigidity
Bowel sounds in early phase
Paralytic ileus causes absent bowel sounds
Hypoxaemia
In severe:
Gross hypotension
Pyrexia
Tachypnoea
Ascites
Pleural effusion
Body wall staining around umbilicus (Cullens sign) or Grey Turner's (flanks)
193
Q

Cullen’s sign

A

Body wall staining around the umbilicus

194
Q

Grey Turner’s sign

A

Body wall staining on the flanks

195
Q

Aetiology of acute pancreatitis

A

90% are caused by gallstones, alcohol, post-ERCP or idiopathic

Idiopathic
Gallstones
Ethanol
Trauma
Steroids
Mumps/malignancy
Autoimmune
Scorpion bite
Hyperlipidaemia
ERCP
Drugs

Viral causes - Coxsackie B, hepatitis, mumps

Drugs - thiazides, valproate, azathioprine
IBD

Alpha 1 antitrypsin deficiency

Sclerosing cholangitis

Vasculitis

Hyperparathyroidism

196
Q

Pathophysiology of acute pancreatitis

A

Occurs as a consequence of premature activation of zymogens releasing proteases that digests surrounding tissues.

Severity is dependent on balance between proteases and anti-proteolytic factors (alpha anti-trypsin)

Occurs due to one of:

  • Defective intracellular transport and secretion of pancreatic zymogens
  • Pancreatic duct obstruction
  • Hyperstimulation of pancreas (alcohol/fat)
  • Reflex of infected contents into CBD
197
Q

Investigations for acute pancreatitis

A

Serum lipase: double the upper limit of normal values

FBC: Leucocytosis

Electrolytes and renal function:

  • Elevated creatinine
  • High anion gap
  • Hypocalcaemia is common

Abdominal XR:
- Rule out perforation and obstruction

Abdominal ultrasound:
- Determines possible cause, such as gallstones

Abdominal CT:

  • Stage severity of the pancreatitis
  • Pancreatic necrosis
  • Pseudocyst
198
Q

Treatment of acute pancreatitis

A
  • Analgesia,
  • IV fluids,
  • O2,
  • Urinary catheter,
  • Naso-jejunal feeding (to avoid pancreatic stimulation),
  • Consider CVP monitoring,
  • ERCP if gallstone obstructing bile duct
199
Q

Complications of acute pancreatitis

A

Pancreatic necrosis (if infected then 3x mortality) - confirmed by CT.

Infected necrosis - fatal without intervention (Infection in 30-70% of necrosis) - IV antibiotics and agrressive surgical debridemnt

Fluid collections

Pancreatic abscess - occurs several months after the attack, requires surgery

Acute pseudo-cyst - occurs 4 weeks after the attack. Can rupture/haemorrhage, requires surgery

Pancreatic ascites from collapsed pseudocyst

Acute cholecystitis

Systemic complications - pulmonary oedema, pleural effusions, consolidation, hypovolaemia, shock, renal dysfunction, hypocalcaemia, hypomagnesaemia, hyperglycaemia, GI haemorrhage, Weber-Christian disease

200
Q

Prognosis of acute pancreatitis

A

80% have mild and recover without complications

5% mortality in mild

30% mortality in severe

201
Q

Classification of acute pancreatitis

A

Glasgow Prognostic Score

Ranson’s criteria (very similar)

3+ = severe pancreatitis

Can also use APACHE II = 8 or more is severe

202
Q

Causes of raised amylase

A
Pancreatitis 
Renal failure
Ectopic pregnancy
Diabetic ketoacidosis
Perforated duodenal ulcers
Mesenteric ischaemia
203
Q

Pathophysiology of chronic pancreatitis

A

Long-term pathological process of pancreatic fibrosis + calcification

  • Obstruction OR reduction of bicarbonate excretion
  • These lead to the activation of pancreatic enzymes, causing pancreatic necrosis

Alcohol causes proteins to precipitate in pancreatic ducts leading to pancreatic dilation and fibrosis.

  • Leads to ductal plugging and obstruction
  • Increased protein secretion, decreases fluid, decreased bicarbonate production

LARGE DUCT subtype:

  • Dilation and dysfunction of large ducts visible on imaging.
  • Occurs more in men, steatorrhoea common, requires surgery to alleviate symptoms.

SMALL DUCT subtype:

  • Occurs more in women, no diffuse pancreatic calcification.
  • Imaging normal - hard to diagnose.
  • Patients respond to pancreatic enzyme replacement.
204
Q

Risk factors for chronic pancreatitis

A

Risk factors:

  • Chronic alcohol use
  • Smoking
  • Genetics (PRSS1, CFTR, SPINK1)
  • Male
  • Black
205
Q

Symptoms of chronic pancreatitis

A
  • Chronic abdominal pain relieved by opiates,
  • Steatorrhoea
  • Abdominal pain
  • Epigastric and radiating to the back
  • Nausea and vomiting
  • Decreased appetite
  • Weight loss
  • Steatorrhoea
206
Q

Signs of chronic pancreatitis

A

Exocrine dysfunction:

  • Malabsorption
  • Diarrhoea/steatorrhoea
  • Protein deficiency

Endocrine dysfunction:
- Diabetes mellitus

Abdominal tenderness

207
Q

Hereditary pancreatitis

A

Rare

Similar to chronic pancreatitis.

Pathophysiology:

  • Genetic mutation in PRSS1.
  • This increases autoactivation of chymotrypsin C

Clinical features:

  • Presents at a young age with epigastric pain
  • Exocrine and endocrine dysfunction

High incidence of pancreatic carcinoma

208
Q

Tropical chronic pancreatitis

A

Developing countries

Associated with type 1 diabetes

Associated with CFTR and SPINK1 genes

Similar to alcoholic pancreatitis presentation

209
Q

Autoimmune chronic pancreatitis

A

High prevalence in Japan

Elevated IgG and serum gammaglobulins

Autoantibodies may be increased

Steroid responsive.

Reversible

210
Q

Investigations for chronic pancreatitis

A
  • Serum amylase (may be normal)
  • US first line then CT -> ERCP: see pancreatic calcification
  • Pancreatic function tests: endocrine/exocrine insufficiency
  • Blood tests: FBC, U&Es, LFTs, Calcium (hypocalcaemia), Amylase (raised), Glucose and HbA1c
  • Secretin stimulation test: positive if pancreatic exocrine function damaged
  • Seen in malabsorption: faecal elastase, serum trypsinogen, urinary D-xylose

Tests of pancreatic function:

  • GOLD standard is collection of pure pancreatic juice after secretin injection (invasive)
  • Pancreolauryl test or PABA test
  • Faecal pancreatic elastase
211
Q

Treatment of chronic pancreatitis

A

Supportive measures:

  • Lifestyle advice - smoking cessation, alcohol abstinence
  • Analgesia (may require coeliac plexus block)
  • ERCP may reduce pain
  • Malabsorption is treated by pancreatic enzyme replacement - Lipase treatment of choice

Octreotide (somatostatin analogue) inhibits pancreatic enzyme secretion and CCK levels

Surgery - pseudocyst decompression, ERCP + lithotripsy

  • If large duct dilation: pancreaticojejunostomy
  • Pancreatoduodenectomy
212
Q

Complications of chronic pancreatitis

A
  • Cobalamin deficiency (B12)
  • Diabetes
  • Pericardial, peritoneal and pleural effusions
  • Pseudocysts
  • Pancreatic carcinoma
  • Increased risk of morbidity and mortality
  • 1/3 die in 10 years
213
Q

Epidemiology of hepatitis A

A

Very common in developing countries, particularly in early life
Most common viral hepatitis
High risk: India, Africa, South and Central America, Middle Esat

RFs

214
Q

Risk factors of hepatitis A

A
  • Personal contact
  • Occupation: residential home staff, sewage worker
  • Travel to high risk areas
215
Q

Hep A virus

A
  • Small unenveloped RNA virus
  • Enterovirus in picornaviridae family
  • Incubation period 2-6 weeks
  • Spread through faecal oral route
  • Can be vaccinated against
216
Q

Symptoms of Hep A infection

A

More severe in older patients, children can be asymptomatic

  • Mild-flu like symptoms
  • Anorexia, nausea, fatigue, malaise, joint pain, mild headache
  • Following this: jaundice
  • Icteric phase: dark urine, pale stools, jaundice, abdominal pain, pruritus, arthralgia, skin rash
217
Q

Pathophysiology of hepatitis A

A
  1. Receptor binding
  2. RNA uncoating
  3. Tranlocation and proteolytic processing. Host ribosomes bind to form polysomes
  4. RNA replication. Genome copied by viral RNA polymerase
  5. Virion assembly
  6. maturation and release.

Shed via biliary tree into faeces

Shedding greatest between 14-21 days after infection

218
Q

Investigations of Hep A infection

A

Specific antibody tests - IgM antibody to Hep A (positive for 3-6 months)
IgG occurs after and persists for many years

LFTs - ALT>AST. Raised ALP
Levels return to normal over several weeks
Raised bilirubin
Modest decrease in albumin

Mild lymphocytosis common

219
Q

Investigations for Hepatitis A infection

A

Specific antibody tests:

  • IgM antibody to Hep A (positive for 3-6 months)
  • IgG occurs after and persists for many years

LFTs:

  • ALT > AST
  • Raised ALP
  • Levels return to normal over several weeks
  • Raised bilirubin
  • Modest decrease in albumin

Mild lymphocytosis common

220
Q

Treatment of hepatitis A infection

A

Mainly supportive - fluids, antiemetics, rest

Avoid alcohol until liver enzymes return to normal

For immediate protection can give immune serum globulin

221
Q

Prognosis of hepatitis A infection

A
  • Excellent
  • Self limiting
  • No long term sequelae
  • No carrier state
  • No chronic liver disease
222
Q

Complications of hepatitis A

A
  • Cholestatic hepatitis,
  • Autoimmune hepatitis,
  • Relapsing hepatitis A infection 4-15 weeks after first illness
223
Q

Hep B antibodies

A

HBsAg:

  • Hep B surface antigen
  • Indicator of active infection
  • If present after 6 months then chronic infection

HBcAg:

  • Hep B core antigen
  • Detected by its antibody IgM then IgG

HBeAg:

  • Hep B e antigen
  • Indicator of viral replication

Chronic infection:
- HbsAg and anti-HBcAg (IgG)

224
Q

Investigation for Hep B infection

A

Blood tests:

  • HBsAg: only detected in first 3-5 weeks after infection, unless chronic infection
  • HBsAg antibodies: in vaccinated people
  • HBeAg: if positive, active infection
  • HBcAg antibodies: past infection
  • FBC, bilirubin, LFTs, clotting, ferritin, lipid profile, ceruloplasmin
  • Test for Hep C and HIV
  • Alpha fetoprotein and liver US for hepatocellular carcinoma screen
225
Q

Hep B virus

A

Hep B virus:

  • Double stranded DNA
  • Hepadnaviridae family
  • Incubation period 40-160 days (average 60-90)
  • Can be e antigen positive or negative (positive = increase rate of replication)
  • Transmission: vaginal or anal intercourse, blood to blood contact, vertical transmission
226
Q

Epidemiology of Hep B infection

A
  • High prevalence in sub-Saharan Africa, most of Asian and Pacific Islands
  • 1 in 350 in UK
  • Starting to decline due to vaccinations
227
Q

Risk factors of Hep B

A
  • Homosexual males
  • Sex workers
  • IV drug users
  • HIV + patients
  • Sexual assault victims
  • Healthcare workers/needlestick injuries
228
Q

Management of Hep B infection

A
  • Avoid unprotected intercourse
  • Notify HPA
  • Supportive treatment - fluids, antiemetics, rest
  • Avoid alcohol
  • Stop unnecessary medications

Give antiviral agents if:

  • Fulminant hepatitis
  • HBeAg positive
  • Pregnancy with high HBV DNA

Give: peginterferon alpha-21 or tenofovir

  • Monitor ALT every 24 weeks, more often if cirrhosis
  • Test for HCC (US and alpha fetoprotein)

Can give hepatitis B immunoglobulin to baby to reduce risk of vertical transmission or just after infection to decrease risk

229
Q

Prognosis of Hep B infection

A

Cirrhosis 20%

Faster progression in Hep C or HIV positive as well

230
Q

Signs of symptoms of Hep B infection

A

Flu like illness: nausea, anorexia, malaise, ache in RUQ

  • Jaundice
  • Disinclination to drink alcohol
  • Dark urine
  • Pale stool
  • Fever
  • In decompensated: ascites, encephalopathy, Gi haemorrhage
231
Q

Clinical features of Hep C infection

A

Acute:
- Asymptomatic,
- Often diagnosed on routine blood testing
20-30% get jaundice

Chronic:

  • Malaise, weakness, anorexia, abdominal pain
  • Symptoms are worse with increased alcohol intake
232
Q

Epidemiology of Hep C infection

A

Large number undiagnosed

214,000 in UK

233
Q

Risk factors of Hep C

A
  • Drug misuse
  • Blood transfusion pre-1991
  • Sexual intercourse
  • Infected pregnant mother
  • Healthcare worker
  • Needlestick injury
  • Tattoo, body piercing
  • Sharing razors/toothbrushes
234
Q

Hep C virus

A
  • Enveloped RNA virus
  • Flaviviridae family
  • Incubation period 6-9 weeks
  • Hep C RNA can be found after 2-4 weeks, antibodies at 6-12 weeks

Transmission: parenteral, bloodborne, sexual contact, vertical transmission

6 genotypes

  • 1 = most common
  • 2, 3, 4, 5, 6
235
Q

Investigations for Hep C infection

A
  • Anti HCV serology
  • HCV RNA quantitative PCR
  • HCV antibody positive for life regardless of treatment
  • US: focal lesions, splenomegaly, cirrhosis
  • Liver biopsy to assess severity
  • Measures of severity: macroglobulin, haptoglobin, apolipoprotein A1, GGT, total bilirubin, transient elastography
  • Test for Hep B and HIV
236
Q

Treatment of Hep C infection

A

Advice:

  • Counselling,
  • Barrier contraception,
  • Alcohol abstinence,
  • Implications of being positive

Drugs effectiveness is related to genotype:

  • Better response in type 2 and 3
  • Weekly subcut peginterferon alpha2a
237
Q

Prognosis of Hep C infection

A
  • 50-85% become chronic carriers
  • 15% will clear virus completely
  • Cirrhosis in 20-30% of chronic
  • 1-4% get HCC, 2-5% get liver failure

Co-infection with Hep B or HIV = worse prognosis

Type 1 more likely to clear spontaneously

238
Q

Hep D virus

A
  • Single stranded RNA virus
  • Enveloped spherical deltavirus
  • Requires presence of Hep B to replicate
  • Patients must be HBsAg positive
  • Delta virus
  • Bloodborne
  • Clinically indistinguishable from Hep B infection
  • Replicated only in liver cells
  • Increases risk of fulminant hepatic failure, chronic liver disease, cirrhosis and HCC with B+D

Chronic in 30-50%

Incubation 3-20 weeks

239
Q

Hep E virus

A
  • Hepeviridae
  • Non-enveloped single stranded RNA
  • Spread via faecal oral route
  • Self-limiting with no chronic infections
  • Incubation 2-9 weeks
  • Fulminant disease in 10%
  • Mild flu like symptoms
240
Q

Define acute liver failure

A

Occurs when liver loses the ability to regenerate or repair so that decompensation occurs.

Characterised by:

  • Hepatic encephalopathy
  • Abnormal bleeding
  • Ascites
  • Jaundice

Fulminant hepatic failure: when failure takes place within 8 weeks of the onset of underlying illness

Late onset/subacute fulminant - when it occurs during 8-26 weeks

Chronic decompensated hepatic failure - after 6 months

241
Q

Risk factors for acute liver failure

A
  • Chronic alcohol abuse
  • Poor nutritional status
  • Female
  • Chronic Hep B/C infection
  • Chronic pain and narcotic use
  • Pregnancy
  • Paracetamol
  • Antidepressant therapy
  • Medications
  • Illicit drug use

FHx:

  • Wilson’s disease,
  • Haemochromatosis
242
Q

Aetiology of acute liver failure

A

Toxins: alcohol, paracetamol, Reye’s syndrome, drugs (co-amoxiclav, ciprofloxacin, doxycycline, erythromycin), ecstasy, cocaine

Infections: viral hepatitis, EBV, CMV, viral haemorrhagic fevers

Cancer:

  • HCC
  • Mets

Pregnancy related: acute fatty liver of pregnancy

Autoimmune liver disease

Metabolic:

  • Wilson’s disease,
  • Alpha 1 antitrypsin deficiency

Vascular:

  • Ischaemia or veno-occulsive disease
  • Budd-Chiari syndrome
243
Q

Presentation of acute liver failure

A
Nausea and vomiting
Malaise 
Abdominal pain
RUQ tenderness
Drowsiness and possibly confusion
Jaundice
Abdominal distension - ascites, hepatomegaly
Papilledema,, hypertension, bradycardia (from cerebral oedema)
Asterixis
Palmar erythema 
Hepatic encephalopathy
244
Q

Investigations for acute liver failure

A

FBC:

  • Thrombocytopenia,
  • Leucocytosis,
  • Anaemia

LFTs:

  • Very raised transaminases,
  • Raised ALP
  • Raised INR,
  • Raised bilirubin,
  • Raised ammonia,
  • Low glucose

May have:

  • Raised lactate,
  • Raised creatinine

Blood cultures:
- Very susceptible to infection

Viral serology

Free copper (Wilson’s),

ABG - metabolic acidosis

Dopper US, CT or MRI
Avoid contrast

245
Q

Management of acute liver failure

A
  • Intensive care management
  • Mannitol to decrease ICP
  • Lactulose + neomycin to reduce ammonia
  • AKI may require haemodialysis or haemofiltration
  • FFP, platelets and anti-fibrinolytic drugs for abnormal bleeding
  • Replace glucose as required
246
Q

Complications of acute liver failure

A
  • Infection: spontaneous peritonitis common
  • Cerebral oedema
  • Haemorrhage
  • Bleeding, sepsis, cerebral oedema, AKI, respiratory failure
247
Q

Prognosis of acute liver failure

A
  • High morbidity and mortality
  • Cause depends on outcome
  • Higher survival if Paracetamol, hep A, pregnancy
248
Q

Define Jaundice

A

Yellow discolouration caused by accumulation of bilirubin in tissue

Not apparent until serum bilirubin is over 35

It can be pre-hepatic, hepatocellular, post-hepatic

249
Q

Breakdown of haemoglobin

A
  • Haemoglobin broken down in spleen to biliverdin.
  • Biliverdin in plasma converted to unconjugated bilirubin and bound with bilirubin
  • Unconjugated becomes conjugated in liver by glucuronic acid
  • Secreted into bowels where converted to urobilinogen by bacteria, secreted in stool as stercobilin
250
Q

Presentation of jaundice

A
  • Any prodromal flu like illness may suggest viral hepatitis
  • Pain suggest gallstones
    painless suggests cancer
  • Change in colour of urine and stools
  • Pruritus
  • Weight loss
  • Alcohol or drug use
    medication history! amitriptyline, erythromycin, COCP, rifampicin, salicylates
251
Q

Examination of a patient with jaundice/signs of liver disease

A
Jaundice - skin and sclera
Spider naevi
Palmar erythema
Gynaecomastia
Testicular atrophy
Flapping tremor
Ascites
Splenomegaly
Finger clubbing
Peripheral oedema
252
Q

Aetiology of pre-hepatic jaundice

A

Gilbert’s syndrome - unconjugated hyperbilirubinaemia
Haemolytic anaemia - spherocytosis, pernicious anaemia
Thalassaemia
Trauma
Crigler-Najjar syndrome

253
Q

Aetiology of hepatic jaundice

A
Viral hepatitis 
HCC
Alcoholic hepatitis
Autoimmune hepatitis
Drug induce hepatitis (Paracetamol)
Decompensated cirrhosis
254
Q

Aetiology of post-hepatic jaundice

A
Gallstones
Bile duct strictures
Common duct stone
Head of pancreas cancer
Tumour at ampulla of Vater
Pancreatitis
GB cancer
Primary biliary cirrhosis
Primary sclerosing cholangitis
255
Q

Blood test results in Pre-hepatic jaundice

A

Raised unconjugated bilirubin
Normal AST, ALP, GGT
Raised reticulocytes
Normal INR, PT

256
Q

Blood test results in hepatic jaundice

A
Raised bilirubin
** Raised AST
ALT>AST
Raised ALP
Raised GGT
Raised INR and PT
Raised urobilinogen with raised or normal bilirubin
257
Q

Blood test results in Post-hepatic jaundice

A
Very high bilirubin
Raised AST
** Raised ALP
** Raised GGT
Raised INR and PT
ALT>AST
Raised urine bilirubin
258
Q

Investigations for jaundice

A
FBC - reticulocytes and blood smear
LFTs
Hepatitis viral serology
Serum ANA and anti-smooth muscle antibody for primary biliary cirrhosis
Ferritin for ?haemochromatosis
Alpha 1 antitrypsin levels
Abdominal US
MRI/MRCP
Liver biopsy
259
Q

What is anti-mitochondrial antibody seen in?

A

Primary biliary cirrhosis

260
Q

What is anti-nuclear and anti-smooth muscle and microsomal antibody seen in?

A

Autoimmune hepatitis

261
Q

What is alpha fetoprotein an indicator of?

A

Hepatocellular carcinoma

262
Q

Tests for haemochromatosis

A

Serum iron
Transferrin
Ferritin

263
Q

Tests for Wilson’s disease

A

Serum and urine copper

Serum ceruloplasmin

264
Q

Antibody positive in Primary Sclerosing

A

Cholangitis

Antinuclear cytoplasmic antibody

265
Q

Epidemiology of alcoholic liver disease

A

Growing incidence
More common in males
Increases with age

RFs
Alcohol consumption - prolonged and heavy
Hep C infection
Female - more rapid progression, requires lower dose of alcohol to achieve
Smoking
Obesity
Over 65
Hispanic
Genetic predisposition - alcohol metabolising enzymes

266
Q

Pathophysiology of alcoholic liver disease

A

3 stages: steatosis (fatty liver) –> alcoholic hepatitis –> alcoholic liver cirrhosis

Alcohol converted to acetaldehyde by alcohol dehydrogenase. At thee same time NAD converted to NADH
NADH inhibits gluconeogenesis and increases fatty acid oxidation

Uses other pathways to metabolise alcohol and this generates free radicals

267
Q

Symptoms of alcoholic liver disease

A
Abdominal pain
Weight loss/gain
Anorexia
Fatigue
Jaundice
Nausea and vomiting
If severe - peripheral oedema, abdominal distension
268
Q

Signs of alcoholic liver disease

A
Hepatomegaly
Palmar erythema
Ascites
Asterixis
Telangiectasia
Pruritus
Fever
Dupytren's contracture
Gynaecomastia
Hypogonadism
Dementia
Peripheral neuropathy
269
Q

Investigations for alcoholic liver disease

A

FBC - anaemia, leucocytosis, thrombocytopaenia, raised MCV

LFTs

  • Raised AST and ALT
  • AST>ALT
  • Raised or normal ALP
  • Raised GGT and bilirubin
  • Normal or prolonged PT and INR

U&Es

Hepatic US
- Hepatomegaly, fatty liver, liver cirrhosis, liver mass, splenomegaly, ascites, portal hypertension

Consider - hepatic virology, iron, ferritin, transferrin, copper, caeruolplasmin, AMA, ANA, AMSA, alpha 1 antitrypsin

Biopsy

270
Q

Management of alcoholic liver disease

A

Removal alcohol
Thiamine for Wernicke-Korsakoff syndrome
Diazepam for DTs
Decrease weight, smoking cessation
Nutritional supplements and multivitamins
Immunisation - influenza, pneumococcal, hep A and B
Corticosteroids - if hepatic encephalopathy
Sodium restriction and diuretics
Liver transplant

271
Q

Prognosis of alcoholic liver disease

A

Improves with alcohol cessation

With abstinence 5 year survival = 90%, without = 60%

If advanced liver disease (jaundice, ascites, haematemesis = 35%

272
Q

Epidemiology of fatty liver disease

A
40-60 years
NAFLD is equal in both sexes
More prevalent in Hispanics
NAFLD 20-30% of population
Non-alcoholic steatohepatitis - 5%
Fatty liver is found in 50% of heavy alcohol users and 94% of obese individuals
273
Q

Define fatty liver disease

A

Steatosis - accumulation of fat in liver
Steatohepatitis - fatty liver causing inflammation
Can be divided into:
- Alcoholic fatty liver disease
- NAFLD - non alcoholic fatty liver disease
Only difference is alcoholic consumption

When inflammation is present can get NASH non-alcoholic steatohepatitis which can progress to cirrhosis and HCC

274
Q

Causes of fatty liver disease

A

Metabolic syndrome - T2DM, impaired glucose tolerance, central obesity, dyslipidemia, hypertension

PCOS

Alcohol excess

Starvation, rapid weight loss, gastric bypass surgery

Total parenteral nutrition and re-feeding syndrome

Hep B, C, HIV

Medication - Amiodarone, tamoxifen, steroids, tetracycline, oestrogens, methotrexate

Wilson’s disease

275
Q

Pathophysiology of fatty liver disease

A

Accumulation of triglycerides and other lipids in hepatocytes
Result of defective fatty acid metabolism, mitochondrial damage (alcohol), insulin resistance or impaired receptors and enzymes

Histologically undistinguished from alcoholic hepatitis
Mallory’s hyaline neutrophil inflammation and pericellular fibrosis

276
Q

Symptoms of fatty liver disease

A

Most do not have symptoms

May have fatigue, malaise or RUQ pain

If advanced - ascites, oedema, jaundice

277
Q

Investigations for fatty liver disease

A

Definitive diagnosis only from biopsy + histology

  • LFTs: mildly raised ALT relative to AST, reverses as disease progresses
  • If raised GGT then alcohol likely cause
  • Fasting lipids and glucose
  • FBC
  • Viral serology
  • US - hyperechoic bright imaging
  • Elastography can be used to determine degree of fibrosis
  • CT or MRI can show extent of disease
  • SteatoTest, NAFLD fibrosis score
  • BIOPSY
278
Q

Management of fatty liver disease

A

Alcohol related fatty liver is managed with abstinence and diet

  • Weight loss
  • Control co-morbidities: BP, diabetes, cholesterol
  • Exercise
  • medications: statins, fibrates,, metformin
  • Bariatric surgery
  • Regular follow up
279
Q

Prognosis of fatty liver disease

A

Steatosis - 1-2% develop cirrhosis in 202 years

Steatohepatitis - 10-12% have cirrhosis in 8 years

280
Q

Define cirrhosis

A

Loss of normal hepatic architecture due to fibrosis with nodular regeneration.

Implies irreversible liver disease and is the final stage of chronic disease from a variety of causes

80-90% of liver parenchyma needs to be destroyed before signs appear

281
Q

Aetiology of cirrhosis

A
Alcohol
Hep B
Hep C
Unknown cause
NAFLD
NASH
Primary biliary cirrhosis
Autoimmune
Primary sclerosing cholangitis
Wilson's disease
Haemochromatosis
Alpha 1 antitrypsin deficiency
Chronic R heart failure
Budd-Chiari syndrome
Drugs - methotrexate
282
Q

Pathophysiology of cirrhosis

A

Chronic injury to the liver results in inflammation, necrosis and eventually fibrosis

Fibrosis is initiated by activation of stellate cells and upregulation of receptors for proliferative and fibrogenic cytokines

Normal matrix replaced by collagens

Loss of endothelial fenestrations –> impaired liver function

Fibrosis causes distortion of hepatic vasculature and can lead to increased intrahepatic resistance and portal hypertension

Portal hypertension can lead to oesophageal varices, hypoperfusion of kidneys, salt and water retention,

Micronodular - caused by alcohol damage and biliary tract disease

Macronodular - chronic hepatitis

283
Q

Signs and symptoms of cirrhosis

A

Vague symptoms: anorexia, nausea and weight loss
In a long period of compensate cirrhosis, patient is well.

Decompensation leads to:

  • Hepatocellular failure
  • Ascites
  • Portal hypertension
  • HCC
  • Osteoporosis
  • Increased infections - particularly spontaneous bacterial peritonitis
284
Q

Investigations for liver cirrhosis

A

Dependent on clinical suspicion of aetiology

  • Hypoalbuminaemia
  • FBC: anaemia, thrombocytopenia, macrocytosis
  • U&E: hyponatraemia, poor renal function would indicate hepatorenal function
  • Raised ferritin in haemochromatosis

Imaging

  • US of liver +/- CT/MRI to detect complications
  • CXR: elevated diaphragm and pleural effusion
  • BIOPSY: gold standard
285
Q

Management of cirrhosis

A

Delay progression and prevent or treat any complications

  • Cholestyramine for pruritus
  • Preventative for osteoporosis
  • Prophylactic antibiotics in upper GI bleeding
  • Stop alcohol
  • Regular exercise
286
Q

Complications of cirrhosis

A
Anaemia
Thrombocytopaenia
Coagulopathy
Oesophageal varices
Ascites 
Spontaneous bacterial peritonitis
HCC
Cirrhotic cardiomyopathy
Hepatopulmonary syndrome 
Portopulmonary hypertension
287
Q

Prognosis of cirrhosis

A

Calculated by Childs-Pugh-Turcotte Classification

Raised score has decreased prognosis

288
Q

Define portal hypertension

A

Abnormally high pressure in the hepatic portal vein

Hepatic venous pressure gradient >10mmHg

289
Q

Anatomy of hepatic portal vein

A

Veins that enter portal hepatic vein

  • Superior mesenteric vein (from small intestine)
  • Splenic vein
  • Inferior mesenteric vein (from large intestine)
290
Q

Aetiology of portal hypertension

A

Pre-hepatic

  • Portal vein thrombosis
  • Splenic vein thrombosis
  • Extrinsic compression (tumours)

Hepatic

  • Cirrhosis
  • Chronic hepatitis
  • Myeloproliferative diseases
  • Idiopathic
  • Toxins
  • Nodular

Post-hepatic

  • Budd-Chiari syndrome
  • Constrictive pericarditis
  • R heart failure
  • Anti-leukaemic drugs/radiation from veno-occlusion of small veins
291
Q

Pathophysiology of portal hypertension

A

Increased vascular resistance in portal venous system - liver damage activates stellate cells and myofibroblasts contributing to abnormal blood flow patterns

Increased blood flow in portal veins
- Splanchnic arteriolar vasodilation caused by excessive release of endogenous vasodilators

Increased portal pressure opens up collaterals connecting to portal and systemic venous system

292
Q

Collaterals to portal system

A

Gastro-oesophageal junction - producing varices
Rectum
Left renal vein
Diaphragm
Anterior abdominal wall via umbilical vein (caput medusae)

293
Q

Budd-Chiari syndrome

A

Occlusion of hepatic vein leading to collateral opening up within the liver with blood diverting though caudate lobe whose short hepatic veins drain directly into IVC

294
Q

Presentation of portal hypertension

A
Haematemesis or melaena
Lethargy, irritability and changes in sleep (encephalopathy)
Increased abdominal girth, weight gain
Abdominal pain, fever (SBP)
Pulmonary involvement
Caput medusae
Splenomegaly
Ascites
Jaundice
Spider naevi
Palmar erythema
Confusion, asterixis
Gynaecomastia 
Testicular atrophy
Hyperdynamic circulation - bounding pulse, low BP, warm peripheries
295
Q

Investigations for portal hypertension

A

LFTs, U&Es, glucose, FBC, clotting screen

Abdominal US - liver and spleen size, ascites, portal blood flow and thrombosis
Doppler for direction of flow in vessels
Elastography for fibrosis
Measure hepatic venous pressure gradient

Liver biopsy

296
Q

Management of portal hypertension

A

Difficult to treat = treat underlying cause
- Beta blockers +/- nitrates or shunt procedure
- Salt restriction and diuretics
- Terlipressin and octreotide can assist control of variceal bleeding
- TIPS: transjugular intraheptatic portosystemic shunt
Connects portal and hepatic veins using stent.
Decompresses portal system
Prevents re-bleeding and ascites
Has a role in: hepatorenal syndrome, hepatic hydrothorax, hepatopulmonary syndrome, Budd-Chiari syndrome

297
Q

Complications of portal hypertension

A
Bleeding from gastric or oesophageal varices (90% get varices, 33% of these bleed)
Ascites (SBP, hepatorenal syndrome)
Portopulmonary hypertension 
Liver failure
hepatic encephalopathy
Cirrhotic cardiomyopathy
298
Q

Presentation of hepatomegaly

A

Vague symptoms: weight loss, reduced appetite, lethargy
May have jaundice, ascites etc.

Smooth hepatomegaly: hepatitis, CHF, sarcoid, early cirrhosis

Craggy hepatomegaly: HCC or 2y tumours

299
Q

Aetiology of hepatomegaly

A

Apparent - low lying diaphragm, early cirrhosis

Venous congestion failure - viral hepatitis, EBV, CMV, malaria, constrictive pericarditis, hepatic vein obstruction

Autoimmune liver disease

Biliary disease - extrahepatic obstruction, primary biliary cirrhosis, primary sclerosing cholangitis

2y cancers, HCC

Amyloidosis, sarcoidosis

Sickle cell, thalassaemia, haemolytic anaemia, myeloma, leukaemia, lymphoma

Haemochromatosis, Wilson’s disease, porphyuria, NAFLD

Drugs - alcohol, drug induced hepatitis

In children - TORCH (toxoplasmosis, other, rubella, CMV, herpes simplex)

300
Q

Aetiology of ascites

A
Cirrhosis (transudate)
Malignancy (exudate)
Heart failure
Nephrotic syndrome - hypoproteinaemia
Protein losing enteropathy
TB
Pancreatitis
Hypothyroidism
Iatrogenic
Budd-Chiari syndrome
301
Q

Causes of haemorrhagic ascites

A

Malignancy
Ruptured ectopic pregnancy
Abdominal trauma
Acute pancreatitis

302
Q

Classification of ascites

A

Only if not affected and not associated with hepatorenal syndrome

  • Grade 1: MILD, only detected on US
  • Grade 2: MODERATE: moderate symmetrical distension of abdomen
  • Grade 3: LARGE - marked abdominal distension
303
Q

Pathophysiology of ascites

A

Transudates are the result of increased pressure in hepatic portal vein e.g. due to cirrhosis

Exudates are actively secreted due to inflammation - raised protein, LDH and WCC, low pH and glucose

Sodium and water retention occurs due to peripheral arterial vasodilation and consequent reduction in effective blood volume

  • NO, ANP and prostaglandins vasodilation
  • Decrease blood volume leads to increase RAAS

Portal hypertension - exerts a local hydrostatic pressure and leads to increase production of lymph and transudate into peritoneal cavity

Low serum albumin - may contribute to low plasma oncotic pressure

304
Q

Signs and symptoms of ascites

A

Abdominal distension and discomfort
Weight gain - due to water retention
Nausea
Appetite suppression - due to compression of bowels and stomach
Increased dyspnoea due to limited venous return from legs and impaired lung expansion

Stigmata of liver disease and cirrhosis
Virchow’s node - if peritoneal carcinoma

305
Q

Investigations for ascites

A
  • Confirm presence of ascites
  • Find cause
  • Assess complications
  • FBC, U&Es, LFTs, TFTs, clotting

US - can detect small amounts and show causative pathology

CXR - pleural effusion, pulmonary mets, heart failure

Aspiration of fluid

  • Neutrophils > 250 = SBP
  • Measure protein - transudate or exudate
  • Cytology for malignant cells
306
Q

Management of ascites

A

Salt and water intake restriction

Regular weights

  1. Spironolactone (monitor for hyperkalaemia)
  2. Loop diuretics (Monitor for hyponatraemia)
  3. Paracentesis - if large or refractory ascites
    - TIPS if > 3 per month
    - Catumaxamab
307
Q

Define hepatic encephalopathy

A

Spectrum of neuropsychiatric abnormalities in patients with liver disease after exclusion of other known brain disease.
Can be covert or overt

Grades 0-4
0 - subclinical, normal mental status (minimal changes in memory, co-ordination or concentration)
1 - mild confusion, euphoria or depression
2 - drowsiuness, lethargy, gross defects in performing mental tasks
3 - rousable, unable to perform mental tasks, disorientated in time and place. incomeprehensible speech
4 - coma +/- response to painful stimuli

308
Q

Precipitating factors for hepatic encephalopathy

high dietary protein

A
GI bleeding
Constipation
Infection, including SBP
Diuretic therapy
TIPS
Surgery
Progressive liver damage
Development of HCC
Sedative drugs
309
Q

Features of hepatic encephalopathy

A
Personality changes
Intellectual impairment
Decreased level of consciousness
Reversal of sleep rhythm
Nausea and vomiting
Confusion
Irritability
Weakness
Coma
Hyper-reflexia
Increased tone
Fetor hepaticus - sweet smell to breath
Asterixis
Constructional apraxia
Decreased mental function
310
Q

Investigations in hepatic encephalopathy

A
Diagnosed clinically
Will have deranged LFTs
- Psychometric tests
- Increased ammonia levels
- EEG (decreased alpha waves)
- Visual evoked response
311
Q

Management of hepatic encephalopathy

A

Early diagnosis
Management of precipitating factors
- Lactulose - decreased nitrogen load from gut
- Antibiotics - lower amino acid production by decreasing concentration of ammonia forming colonic bacteria
(neomycin, vancomycin, metronidazole)
- IV fluids as required

312
Q

Pathophysiology of hepatic encephalopathy

A

Ammonia is by product of colonic bacteria catabolism of nitrogenous sources such as ingested protein and secretion of urea nitrogen

Impaired liver function leads to impaired ammonia clearance

Cirrhosis leads to portosystemic shunting which also decreased ammonia clearance

increased ammonia = alteration of cerebral concentration of aminio acids and this affects neurotransmitter synthesis

313
Q

Phases of drug metabolism

A

Phase 1 - oxidation reactions catalysed by enzyme’s of which P450 is the most important

Phase 2 - conjugation
Formation of covalent bond between drug and endogenous substrate
- usually in hepatic cytoplasm, makes it water soluble for excretion

314
Q

Rules for prescribing in liver disease

A

No general rules for modifying drug doses in liver disease

Changes in metabolism alters efficacy and toxicity

If hypoalbuminaemia then protein bound drugs may be present in toxic amounts

Decreased clotting - increased sensitivity to anticoagulants

Fluids overload can worse ascites

Avoid hepato-toxic drugs

315
Q

Renal control of BP

A

Decreased BP = decreased renal perfusion at juxtaglomerular apparatus
= RENIN secretion from kidneys

Angiotensinogen – renin –> angiotensin I
Angiotensin I –ACE (lungs –> angiotensin II
285
Functions of angiotension II
1. Increased sympathetics
2. Na+ and water retention
3. Aldosterone secretion
4. Arteriolar vasoconstriction
5. ADH secretion from posterior pituitary (increase water absorption)
6. Increased thirst

316
Q

Epidemiology of renovascular disease

A
7% of over 65s
increases with age
FHx of CV or renovascular disease
More common in younger women (fibromuscular dysplasia) and older men (atherosclerosis)
Increased in Caucasians
RFs
Obesity
Hyperlipidaemia
Hypertension
Renal impairment
Other vascular disease
Diabetes
Smoking
317
Q

Aetiology of renal hypoperfusion

A
Renal artery atheroma
Fibromuscular dysplasia
Prolonged hypotension
Embolic renal disease
Renal artery or aortic dissection
Neurofibromatosis 
Renal AV malformation
Takayasu's arteritis
318
Q

Pathophysiology of renovascular disease

A

Atherosclerosis is most common
Normally develops at renal artery ostium on luminal surface of aorta/proximal renal artery
Atheroma obstructs blood flow
Chronic renal ischaemia

In India and Far East - Takayasu’s arteritits most common
Fibromuscular dysplasia affects distal renal artery

319
Q

Presentation of renovascular disease

A

Patients are often asymptomatic

Hypertension
- Abrupt severe onset in middle or older aged patients
Biochemical or clinical evidence of renal impairment during treatment ARB or ACEi
Decompensation of congestive heart failure - recurrent episodes of acute pulmonary oedema

320
Q

Investigations for renovascular disease

A
U&amp;Es
Blood glucose
24 hour urine protein excretion 
Urinalysis for RBCs and casts
Serology to rule out SLE or vasculitis 
Lipid profile - likely to have atherosclerotic disease
Renal US

If thought to be amenable to intervention - angiography

321
Q

Management of renovascular disease

A

Optimise vascular profile - smoking cessation, diabetes, statins, hypertensive therapy

Avoid ACEi and ARBs

Avoid nephrotoxic drugs

Angioplasty and stenting is first line (indicated in pulmonary oedema, severe for refractory hypertension)

Open/endovascular surgery to reconstruct stenosed artery

322
Q

Complications of renovascular disease

A
End organ damage from uncontrolled hypertension
CKD
AKI
Decreased renal function
Refractory angina